实用肿瘤学杂志 ›› 2015, Vol. 29 ›› Issue (1): 61-64.doi: 10.11904/j.issn.1002-3070.2015.01.013

• 综述 • 上一篇    下一篇

酪氨酸激酶受体EphA7在恶性肿瘤中的研究进展

周凤睿, 陈公琰   

  1. 哈尔滨医科大学附属肿瘤医院内一科(哈尔滨 150081)
  • 收稿日期:2014-06-24 出版日期:2015-02-28 发布日期:2015-03-06
  • 通讯作者: 陈公琰,E-mail:chengongyan@hotmail.com.cn
  • 作者简介:周凤睿,女,(1989-),硕士研究生,从事肺癌的靶向诊断与治疗的研究

The progression on tyrosine kinase receptor EphA7 in tumor

ZHOU Fengrui,CHEN Gongyan   

  1. Department of Oncology,The Affiliated Tumor Hospital of Harbin Medical University,Harbin 150081,China
  • Received:2014-06-24 Online:2015-02-28 Published:2015-03-06

摘要: EphA7是酪氨酸蛋白激酶受体家族中的重要成员之一,是细胞排斥和黏附的关键调节因子,也是建立、维持及重塑细胞组织形态的重要参与者。EphA7在不同肿瘤中表达水平的差异提示其在一些肿瘤中可能起到促癌作用,而在另外一些肿瘤中起抑癌作用。研究发现EphA7在急性白血病、多形性恶性胶质瘤、肺癌和肝癌等肿瘤中高表达,且高表达患者预后差,提示EphA7可能作为促癌基因参与了这些肿瘤的发生发展。而在另一些肿瘤中,如结直肠癌、滤泡性淋巴瘤、前列腺癌和胃癌等肿瘤中EphA7呈低表达状态,提示在这些肿瘤中EphA7可能起抑癌作用。EphA7在不同肿瘤中发挥不同的作用,目前对其作用机制尚不十分清楚,但它与肿瘤的发生发展却密不可分。

Abstract: EphA7 is one of the most important members of the Eph family.It is a key regulatory factor of cell adhesion and repulsion,it also contributes to establish men,maintain ance and tissue remodeling in cell morphology.In recent years,its function in tumors has been revealed gradually.It plays a variety of roles in different tumors.The overexpression of EphA7 can be detected in acute leukemia,glioblastomamultiforme,lung cancer and hepatic carcinoma,which suggests EphA7 may be involved in the development of these tumors.While in colon cancer,prostate cancer,follicular lymphoma and gastric cancer,a significant reduction of EphA7 expression with promoter hypermethylation is discovered,which suggests EphA7 play a tumor suppressor role in these tumors.Even though the function of EphA7 is still under exploration,EphA7 and tumor development are inextricably linked,it may have roles in the pathogenesis and development of these carcinomas.

中图分类号: